HIGHLIGHTS
-
COVID-19 symptoms persisted for 180 days, fatigue more commonly.
-
Mild dyspnea and myalgia also have been reported.
-
Despite persistent symptoms, the general quality of life was “good”.
-
COVID-19 survivors were satisfied with their health state.
ABSTRACT
Objective:
This study investigates persistent symptoms, health satisfaction, and general quality of life of COVID-19 survivors at 30, 90, and 180 days after Intensive Care Unit discharge.
Method:
A multicentric prospective cohort study of COVID-19 survivors discharged from eight hospitals in Curitiba - Paraná (Brazil) between September 2020 and January 2022. Eligible COVID-19 survivors were interviewed by phone. A descriptive analysis was performed, and data were compared using Cochran’s Q test and Friedman’s nonparametric test.
Results:
Sixty-two COVID-19 survivors responded to the three interview moments. The most persistent symptoms were fatigue, mild dyspnea, and myalgia. At 30, 90, and 180 follow-up days, most patients reported “good” general quality of life (59.7%, 62.9%, 51.6%, respectively) and a “satisfactory” health state (43.5%, 48.4%, 46.8%, respectively).
Conclusion:
This study revealed the persistence of symptoms after COVID-19 infection; understanding these consequences is the first step towards developing medical treatments and management strategies for these patients.
KEYWORDS:
Coronavirus Infections; Intensive Care Unit; Health Status; Quality of life.